Maturitas
Volume 60, Issue 3 , Pages 235-238 , July 2008

The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids

Received 20 February 2008 ,Revised 9 July 2008 ,Accepted 10 July 2008.

References 

  1. Stewart EA. Uterine fibroids. Lancet. 2001;27:293–311
  2. Aranha RN. Medicalização da saúde da mulher: mulheres esterilizadas em maior risco de histerectomia [tese]. Rio de Janeiro: Universidade Estadual do Rio de janeiro; 2006.
  3. Cook JD, Walker CL. Semin Reprod Med. 2004;22:105
  4. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(10):1589–1592
  5. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid. 2005;308:1589–1592
  6. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 2004;10:207–220
  7. Martucci CP, Fishman J. P-450 enzymes of estrogen metabolism. Pharmacol Ther. 1993;57:237–257
  8. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol. 1996;36:203–232
  9. Cavalieri EL, Stack DE, Devanesan PD, et al. Molecular origin of cancer: catechol estrogen-3,4-quinone as endogenous tumor initiators. Proc Natl Acad Sci. 1997;94:10937–10942
  10. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998;19:1–27
  11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weishilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
  12. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SKJ. Color and genomic ancestry in Brasilians. Proc Natl Acad Sci USA. 2003;100:177–182
  13. Gattas GJF, Soares-Vieira JA. Cytochrome P450-2E1 glutathione S transferase polymorphisms among causacians mullatoes from Brazil. Occup Med. 2000;50:508–511
  14. Lavigne JA, Helzlsouer KJ, Huang HY, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and risk of breast cancer. Cancer Res. 1997;57(24):5493–5497
  15. Nussbaum RL, McInnes RR, Willard HF. Thompson & Thompson genetics in medicine. 6th rev. ed.. Philadelphia: WB Saunders; 2001;pp. 83–95
  16. Creveling CR. The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol. 2003;23(3):289–291
  17. Raftogianis R, Creveling CR, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr. 2000;27:113–124
  18. Worda C, Sator MO, Schneeberger CS, Jantgschev T, Ferlitsch K, Huber JC. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod. 2003;18:262–266
  19. Eriksson AL, Suuriniemi M, Mahonen A, Cheng S, Ohlsson C. The COMT Val158met polymorphism is associated with early pubertal development, height and cortical bone mass in girls. Int Pediatr Res Foundation. 2005;58:71–77
  20. Juo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM. CYP17 CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum Reprod. 2006;21(6):1498–1502
  21. Bochkareva NV, kolomiets LA, Kondakova IV, Stukanov SL, Starova AB, Agarkova LA. Enzymes of estrogen metabolism in endometrial cancer. Oncology. 2006;141(2):240–242
  22. Zhao XM, Xie MQ, Yang DZ, et al. Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer. Zhonghua Fu Chan Ke Za Zhi. 2007;42(2):116–119
  23. Huang CS, Chern HD, Chang KJ, cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res. 1999;59:4870–4875
  24. Huber JC, Schneeberger C, Tempfer CB. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas. 2002;42:1–12
  25. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol. 1991;77:923–926
  26. Mantovani MS, Neto JB, Philbert PM, Casartelli C. Multiple uterine leiomyomas: cytogenetics analysis. Gynecol Oncol. 1999;72:71–75
  27. Marshal RD, Fejzo MLS, Friedman AJ, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyoma and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Gen Chrom Cancer. 1994;11:1–6
  28. Kim H, Neubert JK, Miguel AS, et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain. 2004;109:488–496
  29. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006;13(2):136–144
  30. Gooden KM, Schroeder JC, North KE, et al. Val158Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci. 2007;14(2):117–120

PII: S0378-5122(08)00199-0

doi: 10.1016/j.maturitas.2008.07.001

Maturitas
Volume 60, Issue 3 , Pages 235-238 , July 2008

Article Tools